National Cohort Finds 59.9% Hepatitis B Vaccination Rate Among Liver Transplant Recipients

A US national cohort study using the United Network for Organ Sharing database reported hepatitis B vaccination in 59.9% of liver transplant recipients. Vaccination rates varied by region and other clinical and demographic factors; the supplied abstract did not report sample size.

Hepatitis B vaccination was reported in 59.9% of liver transplant recipients.
Vaccination rates varied by region and clinical and demographic factors.
Sample size and detailed methods were unavailable in the supplied abstract.

A national observational cohort study published in Clinical Infectious Diseases examined hepatitis B vaccination among US liver transplant recipients using the United Network for Organ Sharing database for September 1, 2022, through June 30, 2024. The reported vaccination rate was 59.9%, with wide variation by region and other clinical and demographic factors. The findings identify a vaccination gap in this population, although the supplied abstract does not report the sample size, vaccination definition, specific regional rates, or adjusted associations. The authors suggest that multilevel interventions and use of a more immunogenic vaccine may improve vaccination rates; the abstract does not describe testing these approaches. Full text was unavailable, limiting assessment of the study methods and the clinical implications of the observed variation.

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Source

Clinical Infectious Diseases: Hepatitis B Vaccination for Liver Transplant Recipients in the United States: A National Cohort Study ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.